| Go to the new RSS page and renew your subscription. |
Source: api.bing.com
Seattle Genetics Joins With Pfizer On Cancer Drug Technology - NASDAQ
Seattle Genetics Inc. ( SGEN ) said drug giant Pfizer Inc. ( PFE ) has agreed to pay $8 million upfront and more than $200 million in potential milestone payments for the rights to use its antibody-drug conjugate technology. The biotechnology company's
Source: www.nasdaq.com
No comments:
Post a Comment